Lumiera Health Performance
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Lumiera Health are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Lumiera Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Lumiera Health is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 1.8 M | |
| Total Cashflows From Investing Activities | 312.8 K |
Lumiera |
Lumiera Health Relative Risk vs. Return Landscape
If you would invest (100.00) in Lumiera Health on October 18, 2025 and sell it today you would earn a total of 100.00 from holding Lumiera Health or generate -100.0% return on investment over 90 days. Lumiera Health is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Lumiera, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Lumiera Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lumiera Health's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Lumiera Health, and traders can use it to determine the average amount a Lumiera Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| NHPHF |
Based on monthly moving average Lumiera Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lumiera Health by adding Lumiera Health to a well-diversified portfolio.
Lumiera Health Fundamentals Growth
Lumiera Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Lumiera Health, and Lumiera Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Lumiera Pink Sheet performance.
| Return On Equity | -16.99 | |||
| Return On Asset | -0.43 | |||
| Profit Margin | (2.84) % | |||
| Operating Margin | (2.08) % | |||
| Current Valuation | 1.85 M | |||
| Shares Outstanding | 169.96 M | |||
| Price To Book | 23.28 X | |||
| Price To Sales | 4.83 X | |||
| Revenue | 538.13 K | |||
| EBITDA | 466.2 K | |||
| Cash And Equivalents | 776.26 K | |||
| Total Debt | 1.12 M | |||
| Debt To Equity | 0.90 % | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (2.52 M) | |||
| Earnings Per Share | (0) X | |||
| Total Asset | 2.13 M | |||
Things to note about Lumiera Health performance evaluation
Checking the ongoing alerts about Lumiera Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Lumiera Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Lumiera Health is not yet fully synchronised with the market data | |
| Lumiera Health has some characteristics of a very speculative penny stock | |
| Lumiera Health has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 538.13 K. Net Loss for the year was (1.2 M) with profit before overhead, payroll, taxes, and interest of 265.4 K. | |
| Lumiera Health has accumulated about 776.26 K in cash with (2.52 M) of positive cash flow from operations. | |
| Roughly 29.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Lumiera Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lumiera Health's stock is overvalued or undervalued compared to its peers.
- Examining Lumiera Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Lumiera Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lumiera Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Lumiera Health's pink sheet. These opinions can provide insight into Lumiera Health's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Lumiera Pink Sheet
If you are still planning to invest in Lumiera Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lumiera Health's history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |